US FDA accepts for review Amgen's sBLA for expanded use of Enbrel to treat …

US FDA accepts for review Amgen's sBLA for expanded use of Enbrel to treat …

Enbrel was first approved in 1998 for moderate-to-severe rheumatoid arthritis. Enbrel was approved in 1999 to treat moderate-to-severe polyarticular juvenile idiopathic arthritis, in 2002 to treat psoriatic arthritis, for the treatment of patients with

(Visited 4 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.